Zhu Y - Search Results

1

CpG hypomethylation at proximal promoter and 5'UTR along with IL6 signaling loop associates with MYD88 upregulation in epithelial ovarian cancer.

Li J, Mei B, Zhu Y, Huang J, Li M, Wang D, Huang J, Zhang G. Li J, et al. Among authors: zhu y. Sci Rep. 2024 Dec 28;14(1):30945. doi: 10.1038/s41598-024-81975-x. Sci Rep. 2024. PMID: 39730678 Free PMC article.

2

Prognostic significance of MyD88 expression by human epithelial ovarian carcinoma cells.

Zhu Y, Huang JM, Zhang GN, Zha X, Deng BF. Zhu Y, et al. J Transl Med. 2012 Apr 25;10:77. doi: 10.1186/1479-5876-10-77. J Transl Med. 2012. PMID: 22533866 Free PMC article.

3

Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway.

Huang JM, Zhang GN, Shi Y, Zha X, Zhu Y, Wang MM, Lin Q, Wang W, Lu HY, Ma SQ, Cheng J, Deng BF. Huang JM, et al. Among authors: zhu y. Sci Rep. 2014 Jan 23;4:3840. doi: 10.1038/srep03840. Sci Rep. 2014. PMID: 24452475 Free PMC article.

4

Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.

Liu H, Zhang G, Huang J, Ma S, Mi K, Cheng J, Zhu Y, Zha X, Huang W. Liu H, et al. Among authors: zhu y. J Transl Med. 2016 Apr 27;14(1):104. doi: 10.1186/s12967-016-0845-5. J Transl Med. 2016. PMID: 27118139 Free PMC article.

5

Laparoscopic surgery on broken points for uterine sarcoma in the early stage decrease prognosis.

Liu H, Zhu Y, Zhang GN, Wang C, Li C, Shi Y. Liu H, et al. Among authors: zhu y. Sci Rep. 2016 Aug 9;6:31229. doi: 10.1038/srep31229. Sci Rep. 2016. PMID: 27503773 Free PMC article. Review.

6

Co-expression of CD44/MyD88 is a poor prognostic factor in advanced epithelial ovarian cancer.

Zhu Y, Zhang H, Zhang G, Shi Y, Huang J. Zhu Y, et al. Ann Transl Med. 2019 Mar;7(5):91. doi: 10.21037/atm.2019.01.28. Ann Transl Med. 2019. PMID: 31019941 Free PMC article.

7

Ultrasound-Augmented Phase Transition Nanobubbles for Targeted Treatment of Paclitaxel-Resistant Cancer.

Zhu Y, Zhang G, Li M, Ma L, Huang J, Qiu L. Zhu Y, et al. Bioconjug Chem. 2020 Aug 19;31(8):2008-2020. doi: 10.1021/acs.bioconjchem.0c00364. Epub 2020 Jul 16. Bioconjug Chem. 2020. PMID: 32628454

8

The impact of Pegylated liposomal doxorubicin in recurrent ovarian cancer: an updated meta-analysis of randomized clinical trials.

Li XR, Zhu Y, Zhang GN, Huang JM, Pei LX. Li XR, et al. Among authors: zhu y. J Ovarian Res. 2021 Mar 9;14(1):42. doi: 10.1186/s13048-021-00790-4. J Ovarian Res. 2021. PMID: 33750444 Free PMC article.

9

Association of somatic mutations in BRCA2 BRC domain with chemotherapy sensitivity and survival in high grade serous ovarian cancer.

Zhang G, Zhang J, Zhu Y, Liu H, Shi Y, Mi K, Li M, Zhao Q, Huang Z, Huang J. Zhang G, et al. Among authors: zhu y. Exp Cell Res. 2021 Sep 1;406(1):112742. doi: 10.1016/j.yexcr.2021.112742. Epub 2021 Jul 22. Exp Cell Res. 2021. PMID: 34302857 Free article.

10

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity.

Huang J, Li M, Mei B, Li J, Zhu Y, Guo Q, Huang J, Zhang G. Huang J, et al. Among authors: zhu y. J Transl Med. 2022 Oct 31;20(1):496. doi: 10.1186/s12967-022-03714-y. J Transl Med. 2022. PMID: 36316782 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,820 results

Search Page

Filters